Latest Technology News

Catapult Group International Ltd reported a 16.5% increase in revenue to $116.5 million for FY25, driven by strong subscription growth and improved operational efficiency. The company narrowed its net loss after tax to $8.8 million, signaling progress in its global sports technology strategy.

Ardea Resources has received a $1.2 million R&D tax incentive rebate from the Australian Government, reinforcing its innovative work at the Kalgoorlie Nickel Project and strengthening its financial position.

ASPI Isotopes Inc. has agreed to acquire Renergen Limited in an all-share deal, creating a vertically integrated global entity focused on critical materials for semiconductors, medical isotopes, and green energy. The transaction addresses Renergen’s liquidity challenges and positions the combined company for growth across multiple strategic sectors.

Nanollose has successfully placed the $1.05 million shortfall from its recent entitlement offer, bolstering its capital to advance production and commercialisation of its innovative biomaterials.

Spacetalk Ltd reports robust 3QFY25 results, showcasing strong revenue growth and a sharp reduction in losses as it pivots to a subscription-driven family safety platform.

Whitefield Industrials Limited reported a 10% increase in core operating profit for the year ended March 2025, outperforming its benchmark with a 7.5% portfolio return and raising fully franked dividends to 10.5 cents per share.

Axel REE Limited's latest auger drilling results from Brazil's Poços de Caldas Caldera reveal significant high-grade rare earth mineralisation, expanding the footprint of its Caldas Project and underscoring its potential in the critical minerals sector.

Zoono Group has inked a five-year exclusive contract with Sharpak and OSY to apply its antimicrobial technology on UK soft fruit packaging, aiming to reduce food waste and boost shelf-life.

Clarity Pharmaceuticals has initiated its second registrational Phase III AMPLIFY trial for the Cu-SAR-bisPSMA PET imaging agent targeting biochemical recurrence of prostate cancer. The multi-centre study aims to generate critical data supporting FDA approval and could redefine prostate cancer diagnostics.

Brisbane Broncos Limited revealed solid financial results and operational growth for 2024 at their 2025 Annual General Meeting, highlighting record membership and commercial gains alongside strategic investments.

Despite a tough 2024 NRL season for the men's team, Brisbane Broncos delivered record memberships, increased attendance, and a solid financial performance with a $5.7 million profit.

Dotz Nano Limited has announced a A$1.2 million private placement at a discounted share price, accompanied by options, to bolster working capital and support the commercialisation of its carbon capture technology.